3 results
Primary:The primary objective of Study 218MS305 is to determine whether prolonged-release fampridine (10 mg BID) has a clinically meaningful effect on patient-reported walking ability over a 24-week study period.Secondary:The secondary objectives…
The objective of this investigation is to describe visual outcomes and assess the safety at 12 months (330 - 420 days) post bilateral implantation of the AcrySof® IQ PanOptix* Presbyopia correcting IOL Model TFNT00.
Primary:Sub-study I:- To develop high-quality fast quantitative MRI protocol for multi-contrast imaging of tumour pathophysiology at 3T in esophageal cancer patientsSub-study II:- To determine inter- and intra-session test-retest characteristics of…